Statement on the Efficacy of the AstraZeneca COVID-19 Vaccine (ChAdOx1 nCoV-19) against the SARS-CoV-2 Variants

The document titled Statement on the Efficacy of the AstraZeneca COVID-19 Vaccine (ChAdOx1 nCoV-19) against the SARS-CoV-2 Variants offers a comprehensive insight into Emergency Response and Preparedness, focusing on key issues related to Technical Guidance. It addresses critical health challenges w...

The Global Fund New Funding Model: Lessons from Uganda on Integrating the Integrated Community Case Management Model (iCCM)

Although Uganda has reported a reduction in the mortality rates of children under five years of age (under-five)��from 175 deaths per 1,000 live births in 1990 to 90 deaths per 1,000 live births in 2011��child mortality and morbidity rates remain unacceptably high.1 Pneumonia, diarrhea, and malaria...

Weekly epidemiological Bulletin week 42: 12th -18thOct 2020

We are pleased to share our 42nd weekly epidemiological bulletin for the year 2020. This epidemiological bulletin serves to inform all stakeholders at district, national, and global levels on disease trends, public health surveillance and interventions undertaken in detecting, preventing and respond...

PLAN NATIONAL DE DEVELOPPEMENT SANITAIRE 2016-2020 : vers la couverture sanitaire universelle

La RDC dispose depuis 2010 d’une seconde édition de la Stratégie de Renforcement du
Système de Santé (SRSS-2) appelée à être opérationnalisée, tous les 5 ans, par un Plan
National de Développement Sanitaire (PNDS). Le PNDS 2011-2015 a été évalué et les
résultats ont été présentés à la re...

Global Multidimensional Poverty Index 2019, Illuminating Inequalities

The global Multidimensional Poverty Index (MPI) is one tool for measuring progress against SDG 1. It compares acute multidimensional poverty for more than 100 countries and 5.7 billion people and monitors changes over time.

Communication Style Guide: Africa Centres for Disease Control and Prevention

The Entitys and Institutions of the African Union play a key role in the implementation of the mandates of the AU and continental programmes and initiatives aimed at promoting Africa’s vision of sustainable and inclusive growth and development.Being constituent part of the larger body that makes up...

TB/HIV A Clinical Manual

Untreated HIV infection leads to progressive immunodeficiency and increased susceptibility to infections, including TB. HIV is driving the TB epidemic in many countries, especially in sub-Saharan Africa and, increasingly, in Asia and South America.TB in populations with high HIV prevalence is a lead...

Uganda National Infection Prevention And Control Guidelines 2013

This particular guideline is comprehensive and includes among others the National Infection Prevention and Control Guidelines (MOH, 2004) and the Infection Control: Policies and Procedures (MOH, 2005). IPC guidelines will be used alongside with these and the other technical guidelines such as (1) PE...

Nutrition Care and Support for People Living with HIV

Cardiovascular disease prevention and control Translating evidence into action

Every year, an estimated 17 million people die of cardiovascular disease (CVD) (1). Three fourths of these deaths occur in low- and middle-income countries. In addition, at least one third of the world population is currently at high risk of developing major cardiovascular events; an estimated 1.3 b...

Guidelines for Health Centre III Health Unit Management Committees 2019

These guidelines outline the composition, roles, responsibilities, and management of the proceedings of the Health Unit Management Committees for Health Centre IIIs in Uganda.

Sexual and reproductive health needs of adolescents prenatally infected with HIV in Uganda

The rapid roll-out of anti-retroviral treatment programs has made it possible for perinatally infected infants to live through adolescence and adulthood, thereby engaging in dating and sexual relationships. However, the sexual and reproductive health needs of this unique and rapidly increasing popul...

National Standards for Improving the Quality of Maternal and New Born Care

National Standards for Improving the Quality of Maternal and New Born Care

The First Uganda National Nursing and Midwifery Policy

Like elsewhere in the world, nurses and midwives form the backbone of the health service delivery, constituting more than 60% of the health care work force in Uganda, (MOH, 2007). The quality and satisfaction with care largely depends on nurses and midwives in the health care system, (World Health A...

Ministerial policy statement 2007/2008.

This report is about what the ministry of health has done, is doing and will do in the nearby future.

State of the World Children Report 2019

Globally, at least 1 in 3 children is not growing well due to malnutrition in its more visible forms: stunting, wasting and overweight. At least 1 in 2 suffers from hidden hunger due to deficiencies - often not visible - in essential nutrients

The State of Uganda Population Report 2010

The State of Uganda Population Report development process is a result of many multi sectoral consultative meetings under the leadership of Population Secretariat. We therefore recognize the fundamental inputs of all stakeholders who participated in the production of this report. This year's report c...

Africa CDC Newsletter December 2019

The document titled Africa CDC Newsletter – December 2019 offers a comprehensive insight into Other, focusing on key issues related to Technical Guidance. It addresses critical health challenges within Central Africa, Eastern Africa, Northern Africa, Southern Africa, Western Africa, providing valuab...

Uganda Malaria Indicator Survey 2009

This report presents the findings from the Uganda Malaria Indicator Survey (UMIS) directed by ICF Macro under a contract with the Uganda Bureau of Statistics (UBOS), the Uganda Malaria Surveillance Project Molecular Laboratory at Mulago Hospital, and the National Malaria Control Programme of the Uga...

COVID-19 Scientific and Public Health Policy Update (08 September 2020)

A. Executive summary ● Results from two open non-randomised phase I/II studies with 76 participants assessed the safety and immunogenicity of rAd26 and rAd5 vector-based COVID-19 vaccine in Russia. Findings suggest that the heterologous rAd26 and rAd5 vector-based COVID-19 vaccine has a good safety...